Research Articles | Page 4 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria Oct 2023 Annals of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion Oct 2019 Annals of Hematology Myelodysplastic Syndromes (MDS)
Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes Oct 2020 Annals of internal medicine Myelodysplastic Syndromes (MDS)
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Nov 2020 Annals of Oncology: Official Journal of the European Society for Medical Oncology Myelodysplastic Syndromes (MDS)
A Journey from Blood Cells to Genes and Back Aug 2023 Annual Review of Genomics and Human Genetics Paroxysmal Nocturnal Hemoglobinuria (PNH)
Clonal Hematopoiesis, Inflammation, and Hematologic Malignancy Oct 2023 Annual Review of Pathology: Mechanisms of Disease Aplastic Anemia, Myelodysplastic Syndromes (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH)
Randomized trials with checkpoint inhibitors in acute myeloid leukaemia and myelodysplastic syndromes: What have we learned so far and where are we heading? Dec 2020 Best practice & research. Clinical haematology Myelodysplastic Syndromes (MDS)
MDS/MPN-RS-T Justified Inclusion as a Unique Disease Entity? Jun 2020 Best practice & research. Clinical haematology Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN)
Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality? Jun 2020 Best practice & research. Clinical haematology Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN)
Myelodysplastic/myeloproliferative Neoplasm, Unclassifiable (MDS/MPN-U): More Than Just a "Catch-All" Term? Jun 2020 Best practice & research. Clinical haematology Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN)